Healthcare

Cancer Diagnostics Market to Surge at a CAGR of 7.60% Between 2014 and 2020

Press Release

Global Cancer Diagnostics Market: Snapshot

Owing to the increase in the number of incidences of cancer and rise in the expenditure of healthcare sector, the global market for cancer diagnostics is expected to make a remarkable growth in the future years. Moreover, the technological advancement along with government initiatives and fund contribution that work in favor of the market are also factors estimated to fuel the growth of the market.

Report Overview @ https://www.transparencymarketresearch.com/cancer-diagnostics-market.html

The major factors expected to drive the market for cancer diagnosis is the demand for cancer diagnosis mainly from colorectal cancer, lung cancer, and breast cancer patients. The consumption of tobacco products in emerging economies especially in BRICS nations is also adding to the growth and prevalence of lung cancer worldwide. Similarly, breast cancer diagnosis rate is seen to be higher in the Asia Pacific region as compared to the other regions of the world.

However, the lack of skilled professionals in developing nations may act as a hindrance to the growth of cancer diagnostic market. Adding to that, there is lack of proper reimbursement in the emerging nations and this can also impede the market growth at a global level.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3637

The global cancer diagnostics market is prognosticated to be worth US$168.6 bn by 2020 with a CAGR of 7.60%. The forecast period is set to 2014 to 2020 and is anticipated to be increasing from US$100.9 bn as per the 2013 records.

Cancer Diagnosis Segmentation Opening Lucrative Opportunities for Revenue Generation

The global cancer diagnostics market is categorized on the basis of applications and methods. Based on segmentation by application, the market is classified into Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Lung Cancer, Liver Cancer, Kidney Cancer, Colorectal Cancer (CRC), Breast Cancer, and Blood Cancer. On the basis of method, the cancer diagnosis market is differentiated by Tumor Biomarker Tests, Imaging, Endoscopy, and Biopsy.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3637

Tumor Biomarker tests are further classified into Prostate Specific Antigen Tests, Alpha-Fetoprotein (AFP) Tests, Circulating Tumor Cells (CTC) Tests, CA 19-9 Tests, EGFR Mutation Tests, CA 125 Tests, Carcinoembryonic Antigen (CEA) Tests, HER2 Tests, Anaplastic Lymphoma Kinase (ALK) Tests, BRCA Tests, and KRAS Mutation Tests.

Imaging is further subdivided into Ultrasound, Mammography, Computed Tomography (CT) Scan, Positron Emission Tomography (PET) Scan, and Magnetic Resonance Imaging (MRI) Scan.

The endoscopy segment is further classified into Colposcopy, Bronchoscopy, Sigmoidoscopy, and Colonoscopy. Biopsy is again sub-categorized into Endoscopic Biopsy, Needle Biopsy, and Bone Marrow Biopsy

Asia Pacific to Witness Rapid Growth with Increase in Number of Tobacco Consumers Leading to Mouth Cancer

The global cancer diagnostics market is studied on the basis of key geographies North America, Europe, Asia Pacific, and the Rest of the World. Among these, the region with the most revenue share collection is North America. With more than 40% share, North America is seen to be leading the global market. This is because of the rise in government initiatives so as to support cancer and to create awareness about cancer all over the region. Adding to that, the increase in the number of diagnostic technique prevention is also boosting the cancer diagnostics market in North America.

Apart from North America, Europe is seen to be holding its second position in the cancer diagnostics market worldwide. However, the region prognosticated to show the most promising growth rate and that too at a rapid pace is the Asia Pacific region. This is because of the increase in the number of people consuming tobacco in the emerging nations and the higher level of cancer diagnosis in these nations of Asia Pacific.

Some of the key players in the global cancer diagnosis market are GlaxoSmithKline plc, Abbott Laboratories, bioMerieux, AstraZeneca, and Novartis, and Pfizer.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: https://www.transparencymarketresearch.com

Tags

Related Articles

Close